Another concern with blue dye use is systemic toxicity.

Another concern with blue dye use is systemic toxicity.

• A. No risk
• B. Systemic toxicity
• C. Increased detection
• D. Improved patient comfort

Answer: (B)

Blue dyes used for procedures like sentinel lymph node mapping can enter the bloodstream, so the concern isn’t just superficial staining but systemic toxicity. These dyes can trigger real adverse reactions: isosulfan blue can cause allergic reactions ranging from mild to life-threatening anaphylaxis with low blood pressure and respiratory distress; methylene blue can lead to methemoglobinemia, especially at higher doses or in patients with G6PD deficiency; and methylene blue can interact with serotonergic medications, risking serotonin syndrome. Because of these potential systemic effects, clinicians must assess patient history, monitor closely, and be prepared to treat reactions, rather than assuming there’s no risk.

Blue dyes used for procedures like sentinel lymph node mapping can enter the bloodstream, so the concern isn’t just superficial staining but systemic toxicity. These dyes can trigger real adverse reactions: isosulfan blue can cause allergic reactions ranging from mild to life-threatening anaphylaxis with low blood pressure and respiratory distress; methylene blue can lead to methemoglobinemia, especially at higher doses or in patients with G6PD deficiency; and methylene blue can interact with serotonergic medications, risking serotonin syndrome. Because of these potential systemic effects, clinicians must assess patient history, monitor closely, and be prepared to treat reactions, rather than assuming there’s no risk.